UBS AG Initiates Coverage on Sanofi SA (SAN)
Equities researchers at UBS AG assumed coverage on shares of Sanofi SA (EPA:SAN) in a research report issued on Friday, Analyst Ratings News reports. The firm set a “neutral” rating on the stock.
Shares of Sanofi SA (EPA:SAN) traded down 0.58% during mid-day trading on Friday, hitting €74.01. The stock had a trading volume of 3,287,188 shares. Sanofi SA has a 1-year low of €65.91 and a 1-year high of €87.03. The stock has a 50-day moving average of €24.83 and a 200-day moving average of €24.89. The company has a market cap of €98.129 billion and a price-to-earnings ratio of 31.68.
Separately, analysts at Leerink Swann cut their price target on shares of Sanofi SA from €83.00 ($112.16) to €80.00 ($108.11) in a research note to investors on Monday, October 21st. They now have a “market perform” rating on the stock. Two investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and ten have assigned a buy rating to the company. Sanofi SA has an average rating of “Hold” and a consensus price target of €71.57 ($96.71).
Sanofi SA, formerly Sanofi-Aventis, is a global and diversified healthcare company. The Company discovers, develops and distributes therapeutic solutions focused on patients’ needs.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.